No insider purchase over the last 90 days. The latest was filed 18 Dec 2025.
Every trade that managers of Magle Chemoswed Holding AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. Between 18 October 2025 and 18 October 2026, 5 insiders published 11 filings.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €15k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Biggest ticket of the year: €8,130, bought by Stig Lökke Pedersen and made public on 18 December 2025 (0.92% of market cap). On the buying side, the filings list 2 board members among the declarants.
Across the 886 companies tracked on its exchange, the median is 7 filings; at 11 filings, this issuer sits above that mark. Our records for Magle Chemoswed Holding AB (publ) go back to 2025, with 4 purchases and no sales on the open market in total.
Within a 30-day window, 1 purchase overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The clock since the last published purchase (18 December 2025) now reads 304 days. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
FY ended December 2025 · cache
13 of 13 declarations
Magle Chemoswed Holding AB (publ) is a Swedish company operating in the health and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).